FOXP3 and non-small cell lung carcinoma: Recently, we reported that high VEGFR2 expression in tumor tissue significantly predicted a poor outcome after PD‐1 blockade and closely correlated with the number of FOXP3‐expressing TILs in patients with advanced NSCLC.22